Protagonist Therapeutics Inc (PTGX)

Days of sales outstanding (DSO)

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Receivables turnover		—	—	—	2.46	19.25	6.93	56.81	13.53	1.65	5.13	5.40	2.75	5.34	7.47	7.73	3.85	1.71	0.58	1.87	1.59
DSO	days	—	—	—	148.37	18.96	52.65	6.43	26.97	221.77	71.09	67.64	132.54	68.31	48.85	47.25	94.78	213.43	633.45	195.47	229.15

March 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —

The Days Sales Outstanding (DSO) for Protagonist Therapeutics Inc has shown fluctuations over the historical period. It indicates how long it takes for the company to collect revenue from sales.

The DSO on March 31, 2024, was not provided, but looking at the trend from the previous period, there was a significant increase compared to December 31, 2023, which suggests a potential delay in collecting receivables or a change in sales terms.

The DSO on December 31, 2023, was — days, indicating missing data or an anomaly in reporting for that period. This could impact the overall trend analysis.

The DSO on September 30, 2023, was — days, suggesting that there might be inconsistent reporting or internal practices affecting the collection of sales revenue.

The DSO on June 30, 2023, was 148.37 days, which indicates a relatively long collection period. This could be attributed to various factors such as extended credit terms or challenges in accounts receivable management.

Overall, the data suggests some variability in Protagonist Therapeutics Inc's DSO over the periods analyzed, highlighting the importance of monitoring and managing the efficiency of the company's accounts receivable collection process.